Cargando…

Development and validation of a [(18)F]FDG PET/CT-based radiomics nomogram to predict the prognostic risk of pretreatment diffuse large B cell lymphoma patients

OBJECTIVE: In this study, based on PET/CT radiomics features, we developed and validated a nomogram to predict progression-free survival (PFS) for cases with diffuse large B cell lymphoma (DLBCL) treated with immunochemotherapy. METHODS: This study retrospectively recruited 129 cases with DLBCL. Amo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Mingshan, Yao, Hongyang, Zhang, Peng, Zhang, Lingbo, Liu, Wei, Jiang, Zhiyun, Li, Wei, Zhao, Shu, Wang, Kezheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Nuclear Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121518/ https://www.ncbi.nlm.nih.gov/pubmed/36547676 http://dx.doi.org/10.1007/s00330-022-09301-5

Ejemplares similares

Radiomics–clinical nomogram based on pretreatment 18F-FDG PET-CT radiomics features for individualized prediction of local failure in nasopharyngeal carcinoma
por: Ding, Jianming, et al.
Publicado: (2023)

Radiomics in Gastric Cancer: First Clinical Investigation to Predict Lymph Vascular Invasion and Survival Outcome Using (18)F-FDG PET/CT Images
por: Yang, Liping, et al.
Publicado: (2022)

Baseline (18)F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma
por: Jing, Fenglian, et al.
Publicado: (2023)

Radiomic Features of (18)F-FDG PET in Hodgkin Lymphoma Are Predictive of Outcomes
por: Zhou, Yeye, et al.
Publicado: (2021)

(18)F-FDG PET/CT-based radiomics nomogram could predict bone marrow involvement in pediatric neuroblastoma
por: Feng, Lijuan, et al.
Publicado: (2022)

Development and Validation of a Nomogram Based on (18)F-FDG PET/CT Radiomics to Predict the Overall Survival in Adult Hemophagocytic Lymphohistiocytosis
por: Yang, Xu, et al.
Publicado: (2021)

Prognostic Value of Baseline Radiomic Features of (18)F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma
por: Lue, Kun-Han, et al.
Publicado: (2020)

PET-CT for Evaluation of Spleen and Liver (18)F-FDG Diffuse Uptake Without Lymph Node Enlargement in Lymphoma
por: Rao, Liangjun, et al.
Publicado: (2016)

(18)F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma
por: Eertink, Jakoba J., et al.
Publicado: (2021)

(18)F-FDG PET/CT-based radiomics nomogram for the preoperative prediction of lymph node metastasis in gastric cancer
por: Xue, Xiu-qing, et al.
Publicado: (2022)

(18)F-FDG PET/CT radiomics nomogram for predicting occult lymph node metastasis of non-small cell lung cancer
por: Qiao, Jianyi, et al.
Publicado: (2022)

Incorporating radiomic feature of pretreatment (18)F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma
por: Chen, Yu-Hung, et al.
Publicado: (2020)

(18)F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma
por: Kong, Ziren, et al.
Publicado: (2019)

Ability of (18)F-FDG PET/CT Radiomic Features to Distinguish Breast Carcinoma from Breast Lymphoma
por: Ou, Xuejin, et al.
Publicado: (2019)

(18)F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma
por: Kong, Ziren, et al.
Publicado: (2019)

Development and Validation of (18)F-FDG PET/CT-Based Multivariable Clinical Prediction Models for the Identification of Malignancy-Associated Hemophagocytic Lymphohistiocytosis
por: Yang, Xu, et al.
Publicado: (2022)

Classification of solid pulmonary nodules using a machine-learning nomogram based on (18)F-FDG PET/CT radiomics integrated clinicobiological features
por: Ren, Caiyue, et al.
Publicado: (2022)

Scar sarcoidosis: A rare entity found by 18F-FDG-PET/CT
por: Vidal, M., et al.
Publicado: (2018)

Diagnosis of an unusual case of idiopathic mediastinal fibrosis by (18)F-FDG PET/CT
por: Carbone, Roberto G., et al.
Publicado: (2020)

Gallbladder Involvement of Diffuse Large B-Cell Lymphoma with (18)F-FDG PET/CT
por: Arslan, Esra, et al.
Publicado: (2022)

Texture Analysis Improves the Value of Pretreatment (18)F-FDG PET/CT in Predicting Interim Response of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
por: Sun, Yiwen, et al.
Publicado: (2020)

Assessing radiomic feature robustness to interpolation in (18)F-FDG PET imaging
por: Whybra, Philip, et al.
Publicado: (2019)

The Influence of the Exclusion of Central Necrosis on [(18)F]FDG PET Radiomic Analysis
por: Noortman, Wyanne A., et al.
Publicado: (2021)

Baseline (18)F-FDG PET/CT Radiomics in Classical Hodgkin’s Lymphoma: The Predictive Role of the Largest and the Hottest Lesions
por: Triumbari, Elizabeth Katherine Anna, et al.
Publicado: (2023)

The Value of Diffuse Splenic and Hepatic (18)F-FDG Uptake on PET/CT in Diagnosing Patients with Anemia
por: Deng, Li, et al.
Publicado: (2022)

Mesenteric panniculitis mimicking early recurrence at end-of-treatment evaluation in malignant lymphoma: Differentiation by active surveillance with F-18 FDG PET/CT imaging
por: Ishiyama, Mitsutomi, et al.
Publicado: (2020)

Comparison of FDG PET/CT and Bone Marrow Biopsy Results in Patients with Diffuse Large B Cell Lymphoma with Subgroup Analysis of PET Radiomics
por: Han, Eun Ji, et al.
Publicado: (2022)

Radiomic signatures based on pretreatment 18F-FDG PET/CT, combined with clinicopathological characteristics, as early prognostic biomarkers among patients with invasive breast cancer
por: Jia, Tongtong, et al.
Publicado: (2023)

Preoperative prediction of lymphovascular invasion of colorectal cancer by radiomics based on 18F-FDG PET-CT and clinical factors
por: Yang, Yan, et al.
Publicado: (2023)

FDG PET or PET/CT in Evaluation of Renal Angiomyolipoma
por: Lin, Chun-Yi, et al.
Publicado: (2013)

Prediction of Overall Survival and Progression-Free Survival by the (18)F-FDG PET/CT Radiomic Features in Patients with Primary Gastric Diffuse Large B-Cell Lymphoma
por: Zhou, Yi, et al.
Publicado: (2019)

A Diagnostic Nomogram Based on (18)F-FDG PET/CT for Bone Metastasis of Gastric Cancer
por: Wu, Chunhui, et al.
Publicado: (2021)

Metabolic Radiomics for Pretreatment (18)F-FDG PET/CT to Characterize Locally Advanced Breast Cancer: Histopathologic Characteristics, Response to Neoadjuvant Chemotherapy, and Prognosis
por: Ha, Seunggyun, et al.
Publicado: (2017)

Prognostic model using (18)F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma
por: Driessen, Julia, et al.
Publicado: (2023)

The Clinical Accuracy and Risk Stratification in End of Therapy (18)F-FDG PET/CT in Burkitt Lymphoma
por: Mo, Yi Wen, et al.
Publicado: (2021)

Value of (18)F-FDG PET/CT-Based Radiomics Nomogram to Predict Survival Outcomes and Guide Personalized Targeted Therapy in Lung Adenocarcinoma With EGFR Mutations
por: Yang, Bin, et al.
Publicado: (2020)

Quantitative accuracy of radiomic features of low-dose (18)F-FDG PET imaging
por: Gao, Xin, et al.
Publicado: (2020)

Quantitative classification and radiomics of [(18)F]FDG-PET/CT in indeterminate thyroid nodules
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

[(18)F]FDG-PET/CT radiomics for the identification of genetic clusters in pheochromocytomas and paragangliomas
por: Noortman, Wyanne A., et al.
Publicado: (2022)

Prognostic value of pretreatment (18)F-FDG PET-CT for nasopharyngeal carcinoma patients
por: Huang, Yecai, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0qic67h6dketgiq4aihb80vc5r